Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 24, 2020 08:00 ET | Source: BDA International

Maxim Group & H.C. Wainwright Analysts Confirm Co-Diagnostics (NADSAQ:CODX) Buy Rating with PTs of $20 and $29

New York City, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The global upsurge in COVID-19 has kept testing and Co-Diagnostics (NASDAQ: CODX) under the analysts’ microscope. Within its client circular, the...
April 17, 2020 08:30 ET | Source: BDA International

Co-Diagnostics (NASDAQ:CODX) Continuing to Expand and Evolve to Meet Global Challenges

New York City, April 17, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics (NASDAQ:CODX) Continuing to Expand and Evolve to Meet Global Challenges Co-Diagnostics (NASDAQ:CODX), with its unique, patented...
September 04, 2019 06:30 ET | Source: Co-Diagnostics

Co-Diagnostics, Inc. and LGC, Biosearch Technologies Expand License Agreement for CoPrimer™ Technology

Salt Lake City, Utah, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Diagnostics,” or the “Company”), a molecular diagnostics company with a unique, patented platform...
August 29, 2019 07:00 ET | Source: BDA International

Co-Diagnostics CEO Opens up on Goals and Milestones in Interview with Wall Street Analyzer

New York City, New York, Aug. 29, 2019 (GLOBE NEWSWIRE) -- The Wall Street Analyzer recently completed and published an interview with the CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular...
August 28, 2019 06:30 ET | Source: Co-Diagnostics

Co-Diagnostics, Inc. to Present at 21st Annual Rodman & Renshaw Global Investment Conference Sept 8-10, 2019

Salt Lake City, Utah, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
August 21, 2019 06:30 ET | Source: Co-Diagnostics

Co-Diagnostics, Inc. to Host 2nd Semiannual Distributor Conference on Sept 10-12

Salt Lake City, Utah, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
July 30, 2019 06:30 ET | Source: Co-Diagnostics

Co-Diagnostics, Inc. Vector Control Products Continue to Gain Acceptance Across the US

Salt Lake City, UT, July 30, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
July 18, 2019 06:30 ET | Source: Co-Diagnostics

Co-Diagnostics Inc CoPrimers Provide High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples

Salt Lake City, UT, July 18, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...
October 21, 2014 09:23 ET | Source: ReportsnReports

$7.9B Molecular Diagnostics Market Analysis and Global Review

DALLAS, Oct. 21, 2014 (GLOBE NEWSWIRE) -- Global molecular diagnostics market will reach $7,956.9 million by 2018, growing at a CAGR of 9.7% during the forecast period (2013–2018) according this...